Services

Header

Header

Header

Linkers, Spacers & Crosslinking for Peptide Engineering

Explore a searchable modification library for controlling molecular distance, flexibility, solubility, conjugation, target capture, and triggered payload release. Compare common codes, full modifier names, placement options, installation routes, and application guidance.

147 Curated Entries Searchable Modification Codes Multi-Selection Compatibility Peptide-to-Payload Engineering

Engineer the distance, flexibility, reactivity, and release behavior

Linkers and spacers are functional components of peptide architecture—not passive connectors. Their length, polarity, rigidity, cleavage mechanism, and attachment chemistry can influence steric accessibility, solubility, conjugation efficiency, target binding, intracellular release, pharmacokinetics, and analytical behavior.

This Publication Edition organizes peptide-compatible linker and crosslinking strategies into a practical design library. Each entry is presented by recognized modifier name and code, together with placement, installation, and application guidance.

01
Distance

Control separation and reduce steric interference.

02
Flexibility

Tune molecular motion, presentation, and reach.

03
Reactivity

Match the handle to the intended conjugation route.

04
Release

Select permanent or trigger-responsive attachment.

Final selection should consider the complete construct—including peptide sequence, payload, attachment site, reaction order, purification route, and intended application.

Peptide linker architecture A peptide is connected through a selected spacer and reactive or cleavable chemistry to a payload, with design variables for distance, flexibility, reactivity, and release. PEPTIDE Sequence-defined core SPACER Ahx · PEG · alkyl HANDLE Click · thiol · amine PAYLOAD dye · drug · oligo FLEXIBILITY DISTANCE REACTIVITY OPTIONAL CLEAVAGE CONTROL redox · enzyme · pH · photo · self-immolative
Design logic: begin with the biological or analytical objective, then select the spacer, attachment handle, and cleavage behavior as one integrated architecture.

Find linker, spacer, and crosslinking options by name or code

Search by modifier name, code, chemistry, placement, installation route, or application. Use the family filter to narrow the library, then review final reagent identity and project feasibility with our scientists.

147 entries
Modifier / Full Name Code Family Typical Placement Installation Typical Application
Technical note: Spacer definitions, molecular forms, salts, stereochemistry, and reactive-group variants may differ among suppliers. Final reagent identity, attachment position, and synthesis route are confirmed during project review.

Plan compatible structural modifications

Select multiple linker families to review common combinations, recommended reaction-order considerations, and risks that should be evaluated before synthesis.

Select two or more families

Selections are design prompts—not automatic feasibility approval.

Select modification families to begin

The planner will summarize likely compatibility, synthesis sequence, and major design checks.

Design note: Compatibility depends on sequence, protecting groups, attachment sites, reagent stability, reaction order, and purification.

Start with the molecular problem you need to solve

These recommendations identify a useful starting family; they do not replace sequence-specific design review.

01

Reduce Steric Hindrance

Start with Ahx, AEEA, PEG2, PEG4, or PEG8. Increase length only when the attached component remains inaccessible.

02

Improve Solubility

Favor discrete PEG or polyether spacers; avoid unnecessarily long hydrophobic alkyl linkers.

03

Enable Intracellular Release

Consider disulfide, Val-Cit/PABC, acid-labile, or enzyme-cleavable linkers according to the intended compartment.

04

Install a Site-Specific Payload

Use cysteine/maleimide, azide/DBCO, tetrazine/TCO, or carbonyl/aminooxy chemistry with an orthogonal attachment site.

05

Capture a Transient Interaction

Use diazirine, benzophenone, or aryl-azide photocrosslinkers positioned near the binding interface.

06

Connect a Peptide to Protein or Oligo

Use heterobifunctional PEG crosslinkers or bioorthogonal handles selected for the available reactive groups on both partners.

From linker concept to characterized peptide construct

Sequence design, linker installation, conjugation, purification, and analytical confirmation are planned as one integrated workflow.

01

Design Review

Define the payload, required distance, release mechanism, reactive groups, and intended application.

02

Linker Selection

Choose length, polarity, flexibility, rigidity, cleavability, and orthogonal chemistry.

03

Peptide Synthesis

Plan building blocks, protecting groups, reactive handles, and sequence-specific risks.

04

Linker Installation

Use on-resin, post-cleavage, or hybrid installation according to stability and selectivity.

05

Purification & QC

Apply preparative HPLC, LC-MS identity confirmation, analytical HPLC, and project-specific tests.

06

Release & Scale-Up

Document the final construct and evaluate larger-scale feasibility based on recovery and reagent supply.

Need Help Designing a Linker, Spacer, or Crosslinking Strategy?

Share your peptide sequence, conjugation partner, preferred attachment site, spacer requirements, cleavage objective, and planned downstream use. Our peptide scientists can evaluate linker chemistry, reactive-group compatibility, synthetic route, purification risk, and analytical requirements before manufacturing begins.

Before You Submit Your Project

  • Peptide sequence and desired modification position
  • Conjugation partner or payload
  • Research objective and downstream application
  • Preferred spacer length or linker family
  • Required cleavage or release behavior
  • Available reactive groups and orthogonal handles
  • Required quantity, purity, and formulation
  • Relevant structure or literature reference

How We Evaluate Your Design

Our scientists review synthetic feasibility, attachment-site accessibility, spacer length, reaction selectivity, linker stability, cleavage mechanism, orthogonal chemistry, purification complexity, and project-specific analytical QC. When a requested route is impractical, we explain the limitation and propose a scientifically sound alternative.

Quality Systems & Manufacturing Support

QMS

ISO-Supported Peptide Manufacturing

Complex linker, spacer, and crosslinking projects are supported by controlled synthesis, purification, analytical characterization, documentation, traceability, and project-specific packaging from research through scale-up.

Certified Quality Systems ISO 9001:2015, ISO 13485:2016, and ISO 14001-supported operations.
Advanced Peptide Chemistry Experience with PEGylation, click chemistry, cleavable linkers, crosslinkers, and multifunctional conjugates.
Analytical Characterization Analytical HPLC or UPLC, LC-MS, optional HRMS, and project-specific testing.
Flexible Manufacturing Custom purification, formulation, documentation, and research-to-production scale support.

Linker, spacer, and crosslinking FAQ

FAQ

What is the difference between a linker and a spacer?
A spacer primarily controls distance and flexibility, while a linker may also provide a reactive group, cleavage mechanism, self-immolative function, or connection between two molecular components. The terms overlap in common usage.
How should I choose PEG length?
Use the shortest PEG that provides adequate accessibility and solubility. Longer PEG can increase flexibility, hydrodynamic size, analytical complexity, and purification difficulty.
Can several linkers be combined in one peptide?
Yes, when attachment sites and chemistries are orthogonal. Reaction order, protecting groups, payload stability, purification, and analytical confirmation must be planned together.
Are all listed modifications suitable for on-resin installation?
No. Many reactive, bulky, light-sensitive, or unstable groups are better introduced after cleavage. The library identifies a typical route, but sequence-specific review is required.
Which linker is best for intracellular release?
The answer depends on the target compartment and mechanism. Disulfides respond to reducing environments; Val-Cit/PABC systems are associated with lysosomal proteases; hydrazones and acetals respond to acidic conditions.
How are crosslinked peptides characterized?
LC-MS and analytical HPLC are commonly used for identity and purity. Complex conjugates may require orthogonal chromatography, UV/fluorescence analysis, amino acid analysis, or application-specific testing.
Can you recommend an alternative when direct conjugation is difficult?
Yes. Feasibility review may identify a more suitable attachment site, spacer, bioorthogonal handle, heterobifunctional linker, or staged conjugation route.
Can linkers be used with cyclic or stapled peptides?
Often yes, provided the linker attachment does not compete with the closure chemistry or disrupt the constrained pharmacophore. Reaction order is especially important.
What information is needed for a feasibility review?
Provide the sequence, modification position, conjugation partner, linker preference, desired release mechanism, quantity, purity, formulation, and intended application.
How do I choose between a flexible spacer and a rigid linker?
Flexible spacers such as PEG or aminohexanoic acid can improve accessibility and reduce steric hindrance, while more rigid linkers can preserve a defined distance or orientation. The best choice depends on the target, attachment geometry, and desired biological or analytical behavior.

Recommended Reading

Selected references covering bioconjugation, bioorthogonal reactions, crosslinking, and cleavable linker design.

  1. Hermanson GT. Bioconjugate Techniques. 3rd ed. Academic Press; 2013.
  2. Stephanopoulos N, Francis MB. Choosing an effective protein bioconjugation strategy. Nature Chemical Biology. 2011;7:876–884.
  3. Sletten EM, Bertozzi CR. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angewandte Chemie International Edition. 2009;48:6974–6998.
  4. Bargh JD, Isidro-Llobet A, Parker JS, Spring DR. Cleavable linkers in antibody–drug conjugates. Chemical Society Reviews. 2019;48:4361–4374.
  5. Leriche G, Chisholm L, Wagner A. Cleavable linkers in chemical biology. Bioorganic & Medicinal Chemistry. 2012;20:571–582.
  6. Spicer CD, Davis BG. Selective chemical protein modification. Nature Communications. 2014;5:4740.
Technical note: Linker performance depends on the complete construct, attachment site, reaction sequence, purification conditions, storage, and intended biological or analytical application.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.